To cite this paper use one of the standards below:
Introduction: Alzheimer’s disease (AD) is characterized by cognitive decline, neuroimmune dysregulation, and sleep disturbances. Locus coeruleus (LC) degeneration in AD leads to sleep-wake disruption and impairs norepinephrine (NE) signaling, which may affect microglial activity through β2-adrenergic receptors (β2-ARs). The purinergic receptor P2Y12 also regulates microglial function and sleep homeostasis. However, the relevance of β2-AR-P2Y12 interactions to AD-related sleep disturbances remains poorly described. Methods: We conducted a narrative review using PubMed/MEDLINE and Google Scholar to identify English-language studies published between 2021 and 2026 addressing at least two components of the AD-LC-β2-AR-P2Y12 conceptual axis, complemented by backward citation tracking. Results: Experimental data suggest that β2-AR agonism leads to anti-inflammatory microglial responses, whereas amyloid β plaques (Aβ) and phosphorylated tau accumulation downregulate this pathway, promoting microglial reactivity. Rodent studies associate P2Y12 signaling with microglial chemotaxis, adenosine production, and reduced availability of extracellular NE, while exposure to Aβ reduces P2Y12 expression. Preliminary evidence supports that P2Y12 may attenuate β2-AR-mediated microglial responses and sustained β2-AR activation could suppress P2Y12 signaling through heterologous desensitization and β-arrestin-dependent mechanisms. This bidirectional inhibition potentially contributes to NREM sleep disruption. Conclusion: LC degeneration and β2-AR-P2Y12 imbalance may collectively contribute to NE dysregulation, microglial dysfunction, sleep disturbances, and proteopathy in AD. However, direct evidence exploring this crosstalk remains limited. Further translational and clinical studies are needed to clarify the mechanisms underlying this interaction and whether it represents a potential therapeutic target for sleep disturbances and neuroimmune dysfunction in AD.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper